ITEOS THERAPEUTICS, INC.

Transcripts iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-05 pm EDT			5-day change	1st Jan Change
17.4 ^USD	+3.45%		+0.35%	+58.90%

May. 13	HC Wainwright Adjusts Price Target on iTeos Therapeutics to $46 From $44, Maintains Buy Rating	MT
May. 10	Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains Outperform Rating	MT

Transcripts

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : ITeos Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:00 PM	Jan. 10
Transcript : ITeos Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 08:15 AM	23-01-10
Transcript : ITeos Therapeutics, Inc. Presents at Citi’s 2022 Virtual Immuno-Oncology Summit, Feb-17-2022 01:30 PM	22-02-17
Transcript : iTeos Therapeutics, Inc., Q3 2021 Earnings Call, Nov 10, 2021	21-11-10
Transcript : ITeos Therapeutics, Inc., Q2 2021 Earnings Call, Aug 12, 2021	21-08-12
Transcript : iTeos Therapeutics, Inc. - Special Call	21-06-14
Transcript : iTeos Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 06:10 AM	21-01-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer